STD Urinary Tract Infection Panel
- $541.93
- $95.95
- Save: 82.29%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: ChlamydiaNeisseria gonorrhoeae RNA TMA, CT/GC APTIMA®, CT/GC TMA, CT/NG APTIMA®, CT/NG TMA, Hologic
Chlamydia Trachomatis
Neisseria Gonorrhoeae
Also known as: UA, Complete, Urinalysis UA Complete, Urine Analysis, Complete
Amorphous Sediment
Appearance
Bacteria
Bilirubin
Calcium Oxalate Crystals
Casts
Color
Crystals
Glucose
Granular Cast
Hyaline Cast
Ketones
Leukocyte Esterase
Nitrite
Occult Blood
Ph
Protein
Rbc
Reducing Substances
Renal Epithelial Cells
Specific Gravity
Squamous Epithelial Cells
Transitional Epithelial
Triple Phosphate Crystals
Uric Acid Crystals
WBC
YEAST
The STD Urinary Tract Infection Panel panel contains 2 tests with 29 biomarkers .
Brief Description: The STD Urinary Tract Infection Panel is a targeted diagnostic tool designed to identify sexually transmitted infections (STIs) such as Chlamydia and Gonorrhea, alongside assessing overall urinary tract health through a Urinalysis Complete test. This panel facilitates the early detection of common STIs and urinary tract infections (UTIs), allowing for timely treatment and management.
Collection Method: Urine Collection
Specimen Type: Urine
Test Preparation: Specimen should be collected mid-stream to minimize contamination and improve accuracy. The patient should not have urinated for at least one hour prior to specimen collection. Female patients should not cleanse the labial area prior to providing the specimen.
When and Why the Panel May Be Ordered
Healthcare providers may order this panel for individuals experiencing symptoms of STIs or UTIs, such as pain during urination, unusual discharge, or abdominal pain. It is also recommended for routine screening in sexually active individuals, especially those with new or multiple partners, to ensure early identification and treatment of infections.
What the STD Urinary Tract Infection Panel Checks For
- Chlamydia: A bacterial infection that can affect both men and women, often presenting with minimal symptoms but capable of causing serious reproductive health issues if untreated.
- Gonorrhea: Another bacterial STI that may lead to similar symptoms as chlamydia and can result in significant complications without prompt treatment.
- Urinalysis Complete: This test evaluates various components of urine to detect signs of UTIs, kidney disorders, and other conditions affecting the urinary tract.
Detected Conditions and Diseases
The panel is crucial for diagnosing:
- Chlamydia: Often asymptomatic, it can lead to pelvic inflammatory disease (PID), infertility, and ectopic pregnancy if left untreated.
- Gonorrhea: Symptoms might be mild or mimic other infections; untreated, it can cause PID, infertility, and can disseminate to affect joints and heart valves.
- Urinary Tract Infections: Identified through urinalysis, symptoms include frequent urination, pain, and cloudy urine. UTIs can lead to more severe kidney infections if not addressed.
Clinical Application of Panel Results
Healthcare professionals utilize the panel results to:
- Diagnose and Treat STIs: Promptly identifying and treating STIs like chlamydia and gonorrhea to prevent complications.
- Manage UTIs: Using urinalysis results to diagnose UTIs, guiding appropriate antibiotic therapy.
- Monitor Treatment Efficacy: Assessing the effectiveness of treatment regimens for STIs and UTIs and adjusting as necessary.
The STD Urinary Tract Infection Panel is an essential tool in sexual health and urinary tract health management. By combining tests for common STIs with a comprehensive urinalysis, this panel supports the early detection and treatment of infections, ultimately contributing to better reproductive and urinary health outcomes.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.